Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Fallopian Tube Neoplasms 4Ovarian Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Solitary Fibrous Tumor, Pleural 1Small Cell Lung Carcinoma 1Sarcoma, Alveolar Soft Part 1Prostatic Neoplasms 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Melanoma 1Leiomyosarcoma 1Glioblastoma 1Fallopian Tube Mucinous Adenocarcinoma 1Colorectal Neoplasms 1Carcinosarcoma 1Carcinoma, Endometrioid 1

Interventions

Cisplatin 15Pemetrexed 12pembrolizumab 9Carboplatin 8Nivolumab 7Cyclophosphamide 6Platinum 5Ipilimumab 51,2-diaminocyclohexaneplatinum II citrate 5fludarabine 3Radiotherapy, Intensity-Modulated 3Interleukin-2 3Gemcitabine 3tremelimumab 2durvalumab 2atezolizumab 2aldesleukin 2Radiotherapy 2Radiation 2Photochemotherapy 2Pharmaceutical Preparations 2Methotrexate 2Drug Therapy 2Chemotherapy, Adjuvant 2Cerebral Decortication 2nintedanib 1methoxyamine 1decitabine and cedazuridine drug combination 1cemiplimab 1cediranib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mesothelioma, Malignant × cediranib × 1 year × Clear all
NCT01064648 2026-05-29

Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma

National Cancer Institute (NCI)

Phase 1/2 Active not recruiting
117 enrolled 23 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

Data powered by HemOnc (CC BY 4.0) Colophon âš¡